Honeywell Aerospace
HONA
153.07
-4.32
-2.74%
Honeywell Aerospace
US · HONA
#447 by market cap
Listed 2026
153.07
-4.32
-2.74%
Live - 5344 symbols - heartbeat 263s ago
· 2026-10-08 08:36
Pre-market
151.99
-0.71%
After-hours
152.78
-0.19%
Overnight
152.82
-0.16%
- Market cap
- 48.52B
- P/E (TTM)i
- 24.93
- P/Bi
- -8.52
- EPSi
- 5.62
- Div yieldi
- 0.00%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on HONA?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 3 years
Latest year +12.68% YoY
Margins
- Gross margin
- 34.84%
- Operating margin
- 18.71%
- Net margin
- 10.23%
Income statement
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 13.79B | 15.45B | 17.40B |
| Gross profit | 5.28B | 5.50B | 6.06B |
| Selling & admin expenses | 1.21B | 1.43B | 2.13B |
| Research & development | 506.00M | 567.00M | 677.00M |
| Operating profit | 3.56B | 3.51B | 3.26B |
| Pretax profit | 3.47B | 3.37B | 2.36B |
| Tax | 557.00M | 519.00M | 541.00M |
| Net profit | 2.91B | 2.85B | 1.82B |
| Basic EPS | 9 | 9 | 6 |
| Diluted EPS | 9.11 | 8.89 | 5.62 |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Revenue | 4.07B | 4.29B | 4.35B | 4.52B |
| Gross profit | 1.52B | 1.56B | 1.63B | 1.58B |
| Selling & admin expenses | 365.00M | 383.00M | 628.00M | 722.00M |
| Research & development | 167.00M | 167.00M | 187.00M | 183.00M |
| Operating profit | 991.00M | 1.01B | 815.00M | 676.00M |
| Pretax profit | 933.00M | 1.00B | 646.00M | 378.00M |
| Tax | 147.00M | 148.00M | 134.00M | 122.00M |
| Net profit | 786.00M | 852.00M | 512.00M | 256.00M |
| Basic EPS | 2 | 3 | 2 | 1 |
| Diluted EPS | 2.45 | 2.66 | 1.59 | 0.78 |
Balance sheet
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total current assets | -- | 7.67B | 8.39B |
| Cash & ST investments | -- | 244.00M | 213.00M |
| Inventory | -- | 3.89B | 4.31B |
| Total assets | -- | 16.85B | 17.69B |
| Total current liabilities | -- | 5.82B | 6.58B |
| Short-term debt | -- | 34.00M | 35.00M |
| Long-term debt | -- | -- | -- |
| Total liabilities | -- | 8,017,000,000.00 | 9,189,000,000.00 |
| Total equity | -- | 8.83B | 8.50B |
| Retained earnings | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Total current assets | -- | -- | 9.40B | 9.84B |
| Cash & ST investments | -- | -- | 1.00B | 1.06B |
| Inventory | -- | -- | 4.44B | 4.47B |
| Total assets | -- | -- | 21.36B | 19.37B |
| Total current liabilities | -- | -- | 5.81B | 6.45B |
| Short-term debt | -- | -- | -- | 37.00M |
| Long-term debt | -- | -- | 15.85B | 15.85B |
| Total liabilities | -- | -- | 24,817,000,000.00 | 24,994,000,000.00 |
| Total equity | -- | -- | -3.45B | -5.62B |
| Retained earnings | -- | -- | -- | -- |
Cash flow
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating cash flow | 2.98B | 2.54B | 3.71B |
| Depreciation & amortization | 302.00M | 346.00M | 412.00M |
| Free cash flow | 2.60B | 2.05B | 3.20B |
| Dividends paid | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- |
| Ending cash balance | 145.00M | 244.00M | 213.00M |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Operating cash flow | 277.00M | 748.00M | -225.00M | 571.00M |
| Depreciation & amortization | 102.00M | 110.00M | 111.00M | 122.00M |
| Free cash flow | 176.00M | 615.00M | -362.00M | 448.00M |
| Dividends paid | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- |
| Ending cash balance | 437.00M | 419.00M | 989.00M | 1.06B |
Returns & efficiency
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| ROE %i | -- | 32.25 | 20.78 |
| ROA %i | -- | 16.72 | 10.31 |
| ROIC %i | -- | 31.39 | 27.32 |
| 5-year avg ROE %i | -- | -- | -- |
| EBIT margin %i | 25.84 | 22.72 | 18.24 |
| FCF / sales %i | 18.83 | 13.27 | 18.39 |
| Current ratioi | -- | 1.32 | 1.28 |
| Quick ratioi | -- | 0.60 | 0.57 |
| Debt / assetsi | -- | 1.41 | 1.53 |
| LT debt / equityi | -- | 2.32 | 2.81 |
| Interest coveragei | -- | -- | 3.88 |
| Revenue CAGR (3Y) %i | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- |
| ROA %i | -- | -- | 7.05 | 5.36 |
| ROIC %i | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | 17.48 | 14.78 |
| FCF / sales %i | -- | -- | 15.06 | 13.93 |
| Current ratioi | -- | -- | 1.62 | 1.53 |
| Quick ratioi | -- | -- | 0.80 | 0.76 |
| Debt / assetsi | -- | -- | 74.18 | 82.01 |
| LT debt / equityi | -- | -- | -- | -- |
| Interest coveragei | -- | -- | 3.03 | 2.53 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- |
Quote time 2026-10-08 08:36:42 · For reference only, not investment advice and not tailored to your situation.